The characterization and anatomical distribution of 5-hydroxytryptamine (5-HT) 7 receptor binding sites in brain tissue has been hampered by the lack of a specific radioligand. In the present autoradiographic study, we took advantage of 5-HT 1A knockout and 5-HT 1A/1B double-knockout mice to revisit the pharmacological characterization and anatomical localization of 5-HT 7 binding sites in mouse brain using [ The 5-HT 7 receptor is the most recently identified member of the family of G protein-coupled 5-HT receptors (for review, see Vanhoenacker et al., 2000) . The 5-HT 7 receptor has been cloned from rat Ruat et al., 1993; Shen et al., 1993) , mouse (Plassat et al., 1993) , human (Bard et al., 1993) , and guinea pig (Tsou et al., 1994) . The receptor is positively coupled to adenylate cyclase, preferentially via Gs. It exhibits a high degree of interspecies homology (approximately 95%) but a low sequence homology with other 5-HT receptors (Ͻ40%). In rat and human, three different splice variants have been described to date, which are thought to have similar pharmacology and function (Heidmann et al., 1997; Krobert et al., 2001) . The pharmacological profile of the 5-HT 7 receptor is consistent across all tested species and is characterized by high affinity for the 5-HT 1 agonists 5-CT, 5-HT, and 8-OH-DPAT; and the 5-HT 2 antagonists ritanserin, metergoline, mesulergine, and risperidone. Possible physiological functions for this receptor have been suggested, including relaxation in several vascular preparations (Bard et al., 1993; Shen et al., 1993) and circadian rhythm control via the suprachiasmatic nucleus of the hypothalamus Gannon, 2001) . Because 8-OH-DPAT has been shown to exhibit a relatively high affinity for the 5-HT 7 receptor, multiple functions formerly ABBREVIATIONS:
The 5-HT 7 receptor is the most recently identified member of the family of G protein-coupled 5-HT receptors (for review, see Vanhoenacker et al., 2000) . The 5-HT 7 receptor has been cloned from rat Ruat et al., 1993; Shen et al., 1993) , mouse (Plassat et al., 1993) , human (Bard et al., 1993) , and guinea pig (Tsou et al., 1994) . The receptor is positively coupled to adenylate cyclase, preferentially via Gs. It exhibits a high degree of interspecies homology (approximately 95%) but a low sequence homology with other 5-HT receptors (Ͻ40%). In rat and human, three different splice variants have been described to date, which are thought to have similar pharmacology and function (Heidmann et al., 1997; Krobert et al., 2001) . The pharmacological profile of the 5-HT 7 receptor is consistent across all tested species and is characterized by high affinity for the 5-HT 1 agonists 5-CT, 5-HT, and 8-OH-DPAT; and the 5-HT 2 antagonists ritanserin, metergoline, mesulergine, and risperidone. Possible physiological functions for this receptor have been suggested, including relaxation in several vascular preparations (Bard et al., 1993; Shen et al., 1993) and circadian rhythm control via the suprachiasmatic nucleus of the hypothalamus Gannon, 2001) . Because 8-OH-DPAT has been shown to exhibit a relatively high affinity for the 5-HT 7 receptor, multiple functions formerly attributed to a 5-HT 1A -like receptor (including adenylate cyclase stimulation in gastrointestinal, cardiovascular, and hypothalamic preparations) may be likely attributable to the 5-HT 7 subtype. Atypical antipsychotics, such as clozapine and risperidone, and some antidepressants display high affinity for this receptor. The significance of 5-HT 7 receptor blockade with regard to antipsychotic or antidepressant drug action remains to be elucidated (Eglen et al., 1997; Vanhoenacker et al., 2000) .
The specific distribution of 5-HT 7 receptor mRNA in rat and guinea pig brain is well described Gustafson et al., 1996; Mengod et al., 1996; Kinsey et al., 2001; Neumaier et al., 2001 ). However, the characterization and study of the anatomical distribution of 5-HT 7 receptor binding sites in brain tissue have been hampered by the lack of a specific radioligand. Several attempts have been made using available radioligands in rat brain homogenates (Stowe and Barnes, 1998; Hemedah et al., 1999) or tissue sections Waeber and Moskowitz, 1995; Gustafson et al., 1996; Mengod et al., 1996) . The autoradiographic studies used a relatively nonselective radioligand (i.e., [
3 H]5-CT) in the presence of drugs to mask other binding sites. Very low densities of 5-HT 7 binding sites have been reported in these studies, whereas a relatively high abundance of 5-HT 7 receptor mRNA or 5-HT 7 immunoreactivity has been reported in rat brain (Gustafson et al., 1996; Mengod et al., 1996; Kinsey et al., 2001; Neumaier et al., 2001 ). The authors have concluded that the masking compounds added in these autoradiographic studies might have sufficient affinity for the 5-HT 7 receptor to occupy part of the 5-HT 7 binding sites at the concentration used, thus occluding full visualization of this receptor. An attempt to label 5-HT 7 receptors in hamster brain has also been made using [
3 H]8-OH-DPAT in the presence of pindolol for 5-HT 1A receptor occlusion (Duncan et al., 1999) . However, no pharmacological characterization was presented in the latter study. Furthermore, the concentration of [ 3 H]8-OH-DPAT (1.8 nM) used by Duncan and colleagues seems to be very low with respect to its moderate affinity for 5-HT 7 receptor binding sites in recombinant cell lines or in rat brain tissue homogenates (K i of 30 -65 nM; Lovenberg et al., 1993; Eglen et al., 1997; Krobert et al., 2001) .
In the present autoradiographic study, we took advantage of 5-HT 1A knockout and 5-HT 1A/1B knockout mice to revisit the anatomical localization and pharmacological characterization of 5-HT 7 binding sites in mouse brain using [
3 H]5-CT and [
3 H]8-OH-DPAT. We tested the hypothesis whether the 5-HT 1A and 5-HT 1B/1D masking compounds added in the previous [
3 H]5-CT autoradiographic studies (Waeber and Moskowitz, 1995; Gustafson et al., 1996; Mengod et al., 1996) truly occluded the 5-HT 7 receptor binding sites at the concentration used. In mice lacking the 5-HT 1A receptor, we performed concentration binding studies to determine the suitable concentration of [ 3 H]8-OH-DPAT for labeling of 5-HT 7 receptor binding sites. The 5-HT 7 binding sites were characterized by measuring the potency of several compounds, including a selective 5-HT 7 receptor antagonist (SB-269970; Hagan et al., 2000) to inhibit 5-HT 7 binding sites. This study provides a detailed anatomical localization of 5-HT 7 receptor binding sites throughout the brain of 5-HT 1A and 5-HT 1A/1B knockout mice and addresses the controversial issue of the atypical feature of [
3 H]5-CT binding sites observed in 5-HT 1A receptor-containing regions (Waeber and Moskowitz, 1995; Castro et al., 1997) .
Experimental Procedures
Generation of 5-HT 1A Knockout and 5-HT 1A/1B DoubleKnockout Mice 5-HT 1A receptor knockout mice had been generated as described previously (Ramboz et al., 1998) . 5-HT 1A/1B double-knockout mice were obtained by first crossing homozygous 5-HT 1A knockout mice with previously generated homozygous 5-HT 1B receptor knockout mice . This first cross led to offspring that were heterozygous for both the 5-HT 1A and 5-HT 1B mutant alleles. Subsequent breeding of the heterozygote mice led to the generation of double-knockout mice. Southern blot analysis of tail DNA was used to determine which mice were homozygous mutant for both receptors. All the experiments described in this study have been carried out in accordance with the Guide for the Care and Use of Laboratory Animals as adopted and promulgated by the National Institutes of Health.
Tissue Preparation for Radioligand Autoradiography
Knockout or wild-type mice were asphyxiated by carbon dioxide and decapitated (n ϭ 3 in each group). Brains were immediately removed from the skull and rapidly frozen in dry ice. Frontal sections (20 m in thickness) were cut using a cryostat-microtome (Microm HM505E; Microm International GmbH, Walldorf, Germany) and thaw-mounted on adhesive microscope slides (Superfrost ϩ Plus; VWR, West Chester, PA). The sections were kept at Ϫ70°C until use. The sectioning protocol for the regional distribution study included series of coronal sections covering the entire brain with an interspace of 200 m. Adjacent sections at the level of septum, thalamus, and substantia nigra were used to generate concentration binding and inhibition curves.
Receptor Autoradiography
Sections were thawed and dried under a cold air stream and then preincubated for 3 ϫ 10 min in 50 mM Tris buffer, pH 7.4, at ambient temperature by immersing the sections on the microscope slides in a 400-ml jar.
[ -HT, and 5-CT (using 10 concentrations per compound within a range of 10 pM to 100 M) was performed at the level of the septum.
For both radioligands, nonspecific binding was measured in the presence of 10 M 5-HT (inhibition study) or 10 M SB-269970 (distribution study). After incubation, the excess radioligand was washed off by immersing the microscope slides in a jar (2 ϫ 5 min for both radioligands) with the respective incubation buffer at 4°C, followed by a quick rinse in water and drying under a cold air stream. The sections and standard tritrated microscales were placed in a light-tight cassette and covered with light-sensitive Autoradiograms were digitized using a high-resolution scanner (Agfa Arcus II; AGFA Corp., Ridgefield Park, NJ) and Adobe PhotoShop 5.0 (Adobe Systems, Mountain View, CA). Autoradiograms were quantified using Image Gauge version 3.12 (Fujifilm, Tokyo, Japan). Optical densities in the anatomical regions of interest were transformed into levels of bound radioactivity after calibration of the image analyzer with gray values generated by the coexposed standards. Radioligand binding signal in the absence and presence of competitors was expressed in femtomoles per milligram of protein.
Nonspecific ligand binding was determined in adjacent sections incubated with 10 M 5-HT or 10 M SB-269970.
Ligand concentration binding curves and sigmoidal inhibition curves were generated and fitted by nonlinear regression analysis using GraphPad Prism software (GraphPad Software, San Diego, CA). The B max , K D , and pIC 50 (Ϫlog IC 50 ) values were derived from the curve calculation. The IC 50 is the concentration producing 50% inhibition of specific radioligand binding. (Fig. 1a) , globus pallidus (Fig. 1b) , hippocampus (Fig.  1, b and c) , hypothalamus (Fig. 1, b and c) , thalamus (Fig. 1 , b and c) substantia nigra (data not shown), superior colliculus (data not shown), and raphe nuclei (data not shown). Moderate labeling was observed throughout the cortex (Fig.  1 , a-c), caudate putamen (Fig. 1, a and b) , amygdala (data 3 H]5-CT binding sites (2 nM, a-c) by SB-269970 (10 M, aЈ-cЈ) in wild-type mouse septum (a and aЈ), hippocampus, hypothalamus, and thalamus at rostro (b and bЈ) and caudal levels (c and cЈ) visualized by receptor autoradiography (frontal sections). Cpu, caudate putamen; Cx, cortex; GP, globus pallidus; Hip, hippocampal formation; Hyp, hypothalamus; S, septum; Tha, thalamus. Scale bar, 2.2 mm. Fig. 2c ). In the presence of 10 M SB-269970, all the [ 3 H]5-CT receptor binding was displaced in septum, cortex, hypothalamus, amygdala, and thalamus (Fig. 2 , aЈ-cЈ) but not in globus pallidus or substantia nigra (Fig. 2, aЈ and cЈ) . These residual binding sites in the globus pallidus and substantia nigra of 5-HT 1A/1B knockout were, however, displaced by the 5-HT 1D -selective ligand SB-216641 (1 M) (Fig. 2, aЉ and cЉ) . We had previously determined that 1 M SB-216641 was sufficient to occlude all the [ 3 H]GR125743 binding to 5-HT 1D receptor sites in substantia nigra and globus pallidus (data not shown). SB-216641 does not show any affinity (K i Ͼ10 M) for the recombinant h5-HT 7 receptor (Price et al., 1997) . (Fig. 3a) but not in 5-HT 1A knockout mice (Fig. 3b) or 5-HT 1A/1B double-knockout mice (Fig.  3bЈ) . At 2 nM, high densities were measured in wild-type mice (Fig. 3c) , whereas very low densities were measured in 5-HT 1A knockout mice (Fig. 3d) or 5-HT 1A/1B doubleknockout mice (Fig. 3dЈ) . Consistently, lower K D values (1.30 nM, 95% confidence interval 0.35-2.25 nM) were derived in septum of wild-type compared with knockout animals (5-HT 1A knockout 20 nM, 95% confidence interval 14 -27 nM; 5-HT 1A/1B knockout 21 nM, 95% confidence interval 11-31 nM). At 10 nM [
Materials
3 H]8-OH-DPAT high densities were detectable in both wild-type (Fig. 3e) and 5-HT 1A knockout mice septum (Fig. 3f) or 5-HT 1A/1B double-knockout mice (Fig. 3fЈ) (Fig. 4a) compared with the 5-HT 1A and 5-HT 1A/1B knockout mice (Fig. 4, b and c) . The selective 5-HT 7 antagonist SB-269970 (10 M) displaced part of the [ 3 H]8-OH-DPAT binding site densities in wild-type mouse septum (Fig. 4d ) and all the [ 3 H]8-OH-DPAT binding site densities in knockout mice (Fig. 4, e Table 2 ). In wild-type mice, high densities of [ 3 H]8-OH-DPAT binding sites were observed in olfactory system, septum, bed nucleus of the stria terminalis, amygdala, hypothalamus, hippocampal formation, central gray, raphe nuclei, and throughout the cortical mantle (Fig. 5, a-f) . SB-269970 (10 M) displaced part of [ 3 H]8-OH-DPAT binding sites in wild-type olfactory system (Fig. 5aЈ) , septum (Fig. 5bЈ) , bed nucleus of stria terminalis (Fig. 5bЈ) , amygdala (Fig. 5cЈ) , hypothalamus (Fig. 5 , cЈ-eЈ), thalamus (Fig. 5 , cЈ and dЈ), and central gray (Fig. 5fЈ) .
In 5-HT 1A knockout mouse brain high densities of [ 3 H]8-OH-DPAT binding sites were measured in olfactory system (Fig. 5g) , septum (Fig. 5h) , bed nucleus of the stria terminalis (Fig. 5, h and i) , thalamus (Fig. 5, i and j) , amygdala (Fig. 5 , i and j), hypothalamus (Fig. 5, h-k) , and entorhinal cortex (Fig. 5, j-l) . Moderate densities were measured in CA3 field of the hippocampal formation (Fig. 5, j and k) , central gray (Fig. 5l) , and throughout the cortical mantle. Low densities were observed in cerebellum (data not shown). All the [ 3 H]8- OH-DPAT binding sites were displaced by 10 M SB-269970 in 5-HT 1A knockout mice (Fig. 5, gЈ-lЈ) .
Discussion
In the present autoradiographic study, we took advantage of selective pharmacological tools, 5-HT 1A knockout and 5-HT 1A/1B double-knockout mice to revisit the pharmacological characterization and anatomical localization of 5-HT 7 binding sites in mouse brain using (Hoyer et al., 1994; . These include 5-HT 1A (Boddeke et al., 1992) , 5-HT 1B (Voigt et al., 1991) , 5-HT 1D (Bach et al., 1993) , and 5-HT 5A/5B receptors (Erlander et al., 1993) . With the emergence of a selective 5-HT 7 receptor antagonist (SB-269970; Hagan et al., 2000; Lovell et al., 2000) it has now become possible to specifically displace the 5-HT 7 receptor component of [ ]5-CT labeling in the absence of cold compound in wild-type mice was nearly identical to that observed in the presence of a saturating concentration of the selective 5-HT 7 receptor antagonist SB-269970 (Fig. 1) . Slight decrease in [ 3 H]5-CT density was observed in septum, cortex, amygdala, thalamus, and hypothalamus. Similar observations were made in rat brain tissue sections at the level of the septum, cortex, amygdala, thalamus, and hypothalamus (P. Bonaventure, unpublished data). To clarify this unexpected observation we studied the autoradiographic distribution of [ ]5-CT binding sites were observed in restricted brain regions (septum, cortex, amygdala, thalamus, hypothalamus, globus pallidus, and substantia nigra) of 5-HT 1A/1B double-knockout mice (Fig. 2) . In the globus pallidus and sustantia nigra, [ H]5-CT binding sites corresponding to the 5-HT 7 receptor were observed in septum cortex, amygdala, thalamus, and hypothalamus of 5-HT 1A/1B double-knockout mice. Our results demonstrate that despite its high affinity for the 5-HT 7 receptors in tissue homogenates Stowe and Barnes, 1998; Thomas et al., 2000) or for the recombinant receptor heterologously expressed in mammalian cells (Bard et al., 1993; Plassat et al., 1993; Shen et al., 1993) , [ 3 H]5-CT is not a good tracer for measuring 5-HT 7 binding sites autoradiographically.
In several autoradiographic studies Waeber and Moskowitz, 1995; Gustafson et al., 1996; Mengod et al., 1996) using [ 3 H]5-CT in the presence of masking agents, the authors have concluded that the low densities of [ 3 H]5-CT observed under these conditions might be explained by the occupancy of the 5-HT 7 receptor by the masking agents. In Waeber and Moskowitz's (1995) study the masking of 5-HT 1A binding sites by 100 nM 8-OH-DPAT is likely to block a large fraction of the 5-HT 7 receptor binding sites because of the affinity of this compound for the 5-HT 7 receptor Plassat et al., 1993; Ruat et al., 1993; Shen et al., 1993) . In Gustafson et al. (1996) , the concentration of pindolol (160 nM (Markstein et al., 1999; Thomas et al., 1999) demonstrated an interaction of 5-HT 1A and 5-HT 7 receptors in hippocampus. The 5-HT 7 receptor-mediated stimulation of adenylyl cyclase activity by 5-CT seems to be augmented by a mechanism involving 5-HT 1A receptor activation. Therefore, the presence of the 5-HT 1A receptor may be required for the binding of [ 3 H]5-CT to the 5-HT 7 receptor in tissue section. One alternative explanation may be the binding conditions used in this study. Agonist radioligands, which only recognize the high-affinity state of the receptor are also more sensitive to differing salt conditions than antagonists. We repeated the different protocols described in the literature (different incubation buff- (Waeber and Moskowitz, 1995; Castro et al., 1997) . These sites, described by Castro and colleagues as a new serotoninergic recognition site, most likely correspond to the "atypical" 5-HT 1A binding sites described by Waeber and Moskowitz (1995) . (Bard et al., 1993; Lovenberg et al., 1993; Plassat et al., 1993 ). An attempt to label 5-HT 7 receptors in hamster brain has been previously reported using 1.8 nM [
3 H]8-OH-DPAT in the presence of 500 nM pindolol for 5-HT 1A receptor occlusion (Duncan et al., 1999) . It is likely that the binding sites reported in Duncan et al. (1999) correspond to unmasked 5-HT 1A receptor binding sites. Our results show that a low concentration (2 nM; Fig. 3 (Alexander and Wood, 1988) . In the present study, citalopram (up to 10 M), which displays high affinity for the 5-HT uptake sites (Hyttel, 1977) , did not displace any binding sites in the septum, cortex, or striatum of 5-HT 1A knockout or 5-HT 1A/1B double-knockout mice.
Using [ 3 H]8-OH-DPAT, we have studied the brain distribution of 5-HT 7 receptor binding sites with an increased degree of specificity compared with previous studies (Wae- visualized by receptor autoradiography (frontal sections). Autoradiograms of adjacent sections incubated in the presence of 10 M SB-269970 are shown in wild-type (aЈ-fЈ) and 5-HT 1A knockout mice (gЈ-lЈ). Note in cЈ (arrows) the displacement of 5-HT 7 receptor binding sites by SB-269970 in thalamus and hypothalamus. Amyg, amygdala; BNST, bed nucleus of the stria terminalis; CA, fields CA1-3 of Ammon's horn; CG, central gray; Cing Cx, cingulate cortex; DG, dentate gyrus; DR, dorsal raphe nucleus; Ent Cx, entorhinal cortex; Fr Cx, frontal cortex; Hyp, hypothalamus; LS, lateral septum; LSV, lateral septum ventral; MnR, median raphe nucleus; MM, mammillary nucleus; Oc Cx, occipital cortex; ON, olfactory nucleus; Pa Cx, parietal cortex; Pi Cx, piriform cortex; PO, preoptic nucleus; PVA, paraventricular thalamic nucleus; Su, subiculum; Te, temporal cortex; Tha, thalamus. Scale bar, 2.8 mm.
ber and Moskowitz, 1995; Gustafson et al., 1996; Mengod et al., 1996) . The anatomical distribution of the [ 3 H]8-OH-DPAT binding sites observed in knockout mice matched the distribution of 5-HT 7 receptor mRNA and 5-HT 7 receptor immunoreactivity reported in the literature. Within the hippocampal formation, the distribution described in this study, i.e., strong labeling in CA3 and low densities in CA1, parallels the findings described by Neumaier et al. (2001) using 5-HT 7 receptor-specific antibodies. We also found 5-HT 7 receptor binding sites within the dorsal raphe. A 5-HT autoreceptor role for the 5-HT 7 receptor has not been shown previously (Roberts et al., 2001) . Interestingly, in the present study, high densities of 5-HT 7 receptor binding sites were observed throughout the hypothalamus (including the suprachiasmatic nucleus), suggesting a role for 5-HT 7 in the control of neuroendocrine and homeostatic functions. sites were found throughout the brains of mice lacking the 5-HT 1A receptor.
